Grant: CIHR Fellowship
Direct Payment
$150,000.00
Defining the Molecular Events Linking Growth Factor-Induced Signaling with the G1 Cell Cycle Program
FY 2008-09
Summary
Cell division is a fundamental process of life, and a process ruinously exploited by cancer. Although it is well established that cells proliferate in response to growth factors, there remains a profound gap in understanding how the initial step of growth factor stimulation leads to a cellular commitment to divide. Work from our lab has revealed that growth factors are required at two distinct stages in order to drive cell proliferation. The first stage is a result of initial exposure to growth factor where resting cells are aroused and primed for further stimulation several hours later. At this later time, further exposure to growth factor initiates the second stage, allowing primed cells to directly engage the cellular machinery required to cause proliferation. Although scientists have an excellent appreciation of the events initiated within minutes of the first stage and of the events following the second stage, the molecular events that entail "priming" and thus link these two stages are completely unknown. The importance in understanding these intermediate events is vital not only at a fundamental level, but to understanding exactly how hyperproliferative diseases (e.g. cancer) function at the cellular level. This proposal has two aims. The first aim is to define the molecular events linking the two growth factor-dependent stages required for cell proliferation. It is our hypothesis that growth factors prime cells by inducing the expression of specific proteins. The second aim will be to test how priming and the associated priming proteins contribute to tumour development in animals. We hypothesize that priming is an essential component of tumour development and that suppressing the function of priming proteins will suppress the onset of cancer. These findings will ultimately guide the development of therapeutic targets and strategies to be tested in the treatment of cancer and other hyperproliferative disorders.
Department
Program
CIHR Fellowship
Recipient
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
174214
Name
Pennock Steven D
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Defining the Molecular Events Linking Growth Factor-Induced Signaling with the G1 Cell Cycle Program
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cancer; Cell Cycle; Cell Proliferation; Growth Factors; Multiplexing; Protein Phosphorylation; Proteomics; Signal Transduction; Tumorigenesis; Tyrosine Kinases
Abstract
Cell division is a fundamental process of life, and a process ruinously exploited by cancer. Although it is well established that cells proliferate in response to growth factors, there remains a profound gap in understanding how the initial step of growth factor stimulation leads to a cellular commitment to divide. Work from our lab has revealed that growth factors are required at two distinct stages in order to drive cell proliferation. The first stage is a result of initial exposure to growth factor where resting cells are aroused and primed for further stimulation several hours later. At this later time, further exposure to growth factor initiates the second stage, allowing primed cells to directly engage the cellular machinery required to cause proliferation. Although scientists have an excellent appreciation of the events initiated within minutes of the first stage and of the events following the second stage, the molecular events that entail "priming" and thus link these two stages are completely unknown. The importance in understanding these intermediate events is vital not only at a fundamental level, but to understanding exactly how hyperproliferative diseases (e.g. cancer) function at the cellular level. This proposal has two aims. The first aim is to define the molecular events linking the two growth factor-dependent stages required for cell proliferation. It is our hypothesis that growth factors prime cells by inducing the expression of specific proteins. The second aim will be to test how priming and the associated priming proteins contribute to tumour development in animals. We hypothesize that priming is an essential component of tumour development and that suppressing the function of priming proteins will suppress the onset of cancer. These findings will ultimately guide the development of therapeutic targets and strategies to be tested in the treatment of cancer and other hyperproliferative disorders.
Competitiondate
200810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Pennock, Steven D
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~